These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Removal of amantadine hydrochloride by dialysis in patients with renal insufficiency. Ing TS; Mahurkar SD; Dunea G; Hayashi JA; Klawans HL; Markey WS Can Med Assoc J; 1976 Sep; 115(6):515. PubMed ID: 953934 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis. Ohkawa M; Nakashima T; Shoda R; Ikeda A; Orito M; Sawaki M; Sugata T; Shimamura M; Hirano S; Okumura K Chemotherapy; 1985; 31(6):410-6. PubMed ID: 3908006 [TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of aminoguanidine in end-stage renal disease patients on hemodialysis. Foote EF; Look ZM; Giles P; Keane WF; Halstenson CE Am J Kidney Dis; 1995 Mar; 25(3):420-5. PubMed ID: 7872319 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cefepime in subjects with renal insufficiency. Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis. Blum RA; Kohli RK; Harrison NJ; Schentag JJ Antimicrob Agents Chemother; 1989 Sep; 33(9):1470-6. PubMed ID: 2817847 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis. Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427 [TBL] [Abstract][Full Text] [Related]
11. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis. Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis. Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis. Chen N; Lau H; Kong L; Kumar G; Zeldis JB; Knight R; Laskin OL J Clin Pharmacol; 2007 Dec; 47(12):1466-75. PubMed ID: 17954615 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of rilmenidine in patients with chronic renal insufficiency and in hemodialysis patients. Aparicio M; Dratwa M; el Esper N; Fillastre JP; Levaltier B; Lins R; Meyrier A; Mignon F; Ryckelynck JP; Sennesael J Am J Cardiol; 1994 Dec; 74(13):43A-50A. PubMed ID: 7998585 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intravenous pentamidine in patients with normal renal function or receiving hemodialysis. Conte JE J Infect Dis; 1991 Jan; 163(1):169-75. PubMed ID: 1984463 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of moxalactam in anuric children and during hemodialysis. Kaplan SL; Berry PL; Mason EO; Kramer WG Pediatr Pharmacol (New York); 1983; 3(1):29-36. PubMed ID: 6646877 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis. Reitberg DP; Marble DA; Schultz RW; Whall TJ; Schentag JJ Antimicrob Agents Chemother; 1988 Apr; 32(4):503-9. PubMed ID: 3377461 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment. Shyu WC; Pittman KA; Wilber RB; Matzke GR; Barbhaiya RH J Clin Pharmacol; 1991 Apr; 31(4):362-71. PubMed ID: 2037710 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function. Leroy A; Humbert G; Godin M; Fillastre JP Antimicrob Agents Chemother; 1980 Mar; 17(3):344-9. PubMed ID: 7425600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]